Abstrakti
Pluripotent stem cell–derived islets (SC-islets) have emerged as a new source for b-cell replacement therapy. The function of human islet transplants is hampered by excessive cell death posttransplantation; contributing factors in-clude inflammatory reactions, insufficient revascularization, and islet amyloid formation. However, there is a gap in knowledge of the engraftment process of SC-islets. In this experimental study, we investigated the engraftment capability of SC-islets at 3 months posttransplantation and observed that cell apoptosis rates were lower but vascular density was similar in SC-islets compared with human islets. Whereas the human islet transplant vascular structures were a mixture of remnant donor endothelium and ingrowing blood vessels, the SC-islets contained in-growing blood vessels only. Oxygenation in the SC-islet grafts was twice as high as that in the corresponding grafts of human islets, suggesting better vascular functionality. Similar to the blood vessel ingrowth, reinnervtion of the SC-islets was four-to fivefold higher than that of the human islets. Both SC-islets and human islets contained amyloid at 1 and 3 months posttransplantation. We conclude that the vascular and neural engraftment of SC-islets are superior to those of human islets, but grafts of both origins develop amyloid, with potential long-term consequences.
Alkuperäiskieli | englanti |
---|---|
Lehti | Diabetes |
Vuosikerta | 73 |
Numero | 7 |
Sivut | 1127-1139 |
Sivumäärä | 13 |
ISSN | 0012-1797 |
DOI - pysyväislinkit | |
Tila | Julkaistu - heinäk. 2024 |
OKM-julkaisutyyppi | A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu |
Lisätietoja
Publisher Copyright:© 2024 by the American Diabetes Association.
Tieteenalat
- 3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet